Cutia Therapeutics (02487) Announces Monthly Return for November 2025, Issued Shares Increase to 364,730,877

Bulletin Express

Dec 04, 2025

Cutia Therapeutics, incorporated in the Cayman Islands with limited liability, released its monthly return for November 2025. The company’s authorized share capital remains unchanged at 2,500,000,000 ordinary shares with a par value of USD 0.00002 each, totaling USD 50,000.

During November 2025, the number of issued shares (excluding treasury shares) rose from 348,370,511 to 363,368,277, while treasury shares stayed at 1,362,600, bringing the total to 364,730,877. The 14,997,766-share increase resulted from the exercise of share options under the Pre-IPO Equity Incentive Plan.

According to the filing, 14,997,766 share options were exercised under the Pre-IPO Equity Incentive Plan, reducing the outstanding options under this plan from 52,197,774 to 37,200,008. The company reported that no funds were raised (USD 0) during this period from the exercise of these share options. The Post-IPO Equity Incentive Plan recorded no changes for the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1141706948"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141706948\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141706948?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141706948","market":"us","top_or_hot":-1,"title":"Cutia Therapeutics (02487) Announces Monthly Return for November 2025, Issued Shares Increase to 364,730,877","media":"Bulletin Express","content":"<p>Cutia Therapeutics, incorporated in the Cayman Islands with limited liability, released its monthly return for November 2025. The company’s authorized share capital remains unchanged at 2,500,000,000 ordinary shares with a par value of USD 0.00002 each, totaling USD 50,000.</p>\n<p>During November 2025, the number of issued shares (excluding treasury shares) rose from 348,370,511 to 363,368,277, while treasury shares stayed at 1,362,600, bringing the total to 364,730,877. The 14,997,766-share increase resulted from the exercise of share options under the Pre-IPO Equity Incentive Plan.</p>\n<p>According to the filing, 14,997,766 share options were exercised under the Pre-IPO Equity Incentive Plan, reducing the outstanding options under this plan from 52,197,774 to 37,200,008. The company reported that no funds were raised (USD 0) during this period from the exercise of these share options. The Post-IPO Equity Incentive Plan recorded no changes for the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cutia Therapeutics (02487) Announces Monthly Return for November 2025, Issued Shares Increase to 364,730,877</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCutia Therapeutics (02487) Announces Monthly Return for November 2025, Issued Shares Increase to 364,730,877\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cutia Therapeutics, incorporated in the Cayman Islands with limited liability, released its monthly return for November 2025. The company’s authorized share capital remains unchanged at 2,500,000,000 ordinary shares with a par value of USD 0.00002 each, totaling USD 50,000.</p>\n<p>During November 2025, the number of issued shares (excluding treasury shares) rose from 348,370,511 to 363,368,277, while treasury shares stayed at 1,362,600, bringing the total to 364,730,877. The 14,997,766-share increase resulted from the exercise of share options under the Pre-IPO Equity Incentive Plan.</p>\n<p>According to the filing, 14,997,766 share options were exercised under the Pre-IPO Equity Incentive Plan, reducing the outstanding options under this plan from 52,197,774 to 37,200,008. The company reported that no funds were raised (USD 0) during this period from the exercise of these share options. The Post-IPO Equity Incentive Plan recorded no changes for the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02487","symbol_name":"科笛-B","start_time":0,"source_url":"","article_id":"1141706948","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141706948","pubTimestamp":1764853429,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Cutia Therapeutics, incorporated in the Cayman Islands with limited liability, released its monthly return for November 2025. The company’s authorized share capital remains unchanged at 2,500,000,000...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02487":"科笛-B"},"translate_title":"Cutia Therapeutics(02487)公布2025年11月月报表，已发行股份增至364,730,877股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02487":1},"content_text":"Cutia Therapeutics, incorporated in the Cayman Islands with limited liability, released its monthly return for November 2025. The company’s authorized share capital remains unchanged at 2,500,000,000 ordinary shares with a par value of USD 0.00002 each, totaling USD 50,000.\nDuring November 2025, the number of issued shares (excluding treasury shares) rose from 348,370,511 to 363,368,277, while treasury shares stayed at 1,362,600, bringing the total to 364,730,877. The 14,997,766-share increase resulted from the exercise of share options under the Pre-IPO Equity Incentive Plan.\nAccording to the filing, 14,997,766 share options were exercised under the Pre-IPO Equity Incentive Plan, reducing the outstanding options under this plan from 52,197,774 to 37,200,008. The company reported that no funds were raised (USD 0) during this period from the exercise of these share options. The Post-IPO Equity Incentive Plan recorded no changes for the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}